Trial Profile
A single-center observational study to analyze long term survival, efficacy, safety and comorbidities in patients treated with ustekinumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 10 May 2018 New trial record